Up Next
0
Biotech Firm Gilead Hammered
Gilead Sciences shares are getting hammered today after disappointing test results on one of its Hepatitis C drugs, with CNBC's Seema Mody.
Share
Biotech Firm Gilead Hammered
Gilead Sciences shares are getting hammered today after disappointing test results on one of its Hepatitis C drugs, with CNBC's Seema Mody.
Date: 2/17/12
Views: 307
Video by:  CNBC
 
Follow us:
Loading... 1 of 167
Today's Most Watched Videos
Related Videos
Loading... 1 of 56